Patients with breast cancer who delay consultation beyond 90 days have a higher risk for death within 2 years, according to a ...

Key TakeawaysThe type of hormone therapy a woman is prescribed can alter her breast cancer riskEstrogen-only hormone therapy ...

New research reveals that excess weight is linked to an especially high risk of developing breast cancer in postmenopausal ...

The review introduces the molecular subtypes of breast cancer and outlines how altered amino acid metabolism supports tumor ...

Australians aged in their 30s and 40s are experiencing unprecedented and in some cases world-leading rates of 10 different ...

One key recommendation "is not yet widely enough known," said the director of the Annenberg Public Policy Center.

Thousands of women with advanced breast cancer could be denied life-extending drugs because of the “unfair” way they are assessed for use on the health service, a charity has warned. Breast Cancer Now ...

Hormone therapy may be used by young women to relieve symptoms from hormone-­related conditions, menopause, or gynecologic surgery. Long-term use of estrogen/progestin hormone therapy was positively ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

NIH study could help to guide clinical recommendations for hormone therapy use among women under 55 years old.

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

These findings suggest a need to investigate whether age-specific trends are due to guidelines that suggest reduced screening for older age groups,” the researchers wrote.